Marco Mielcarek, Kristin A

Slides:



Advertisements
Similar presentations
Engraftment Syndrome after Autologous Stem Cell Transplantation: An Update Unifying the Definition and Management Approach  Robert Frank Cornell, Parameswaran.
Advertisements

A Low Effective Dose of Interleukin-7 Is Sufficient to Maintain Cord Blood T Cells Alive without Potentiating Allo-Immune Responses  Laurent Pascal, Bénédicte.
Superior depletion of alloreactive T cells from peripheral blood stem cell and umbilical cord blood grafts by the combined use of trimetrexate and interleukin-2.
Sirolimus in Combination with Cyclosporine or Tacrolimus Plus Methotrexate for Prevention of Graft-versus-Host Disease following Hematopoietic Cell Transplantation.
Depletion of Alloreactive Donor T Lymphocytes by CD95-Mediated Activation-Induced Cell Death Retains Antileukemic, Antiviral, and Immunoregulatory T Cell.
How to Treat MDS without Stem Cell Transplantation
Apoptotic Donor Leukocytes Limit Mixed-Chimerism Induced by CD40-CD154 Blockade in Allogeneic Bone Marrow Transplantation  Jian-ming Li, John Gorechlad,
Vaccination of Children following Allogeneic Stem Cell Transplantation
Double Umbilical Cord Blood Transplantation: A Study of Early Engraftment Kinetics in Leukocyte Subsets using HLA-Specific Monoclonal Antibodies  Judith.
LBH589 Enhances T Cell Activation In Vivo and Accelerates Graft-versus-Host Disease in Mice  Dapeng Wang, Cristina Iclozan, Chen Liu, Changqing Xia, Claudio.
Combined CD4+ Donor Lymphocyte Infusion and Low-Dose Recombinant IL-2 Expand FOXP3+ Regulatory T Cells following Allogeneic Hematopoietic Stem Cell Transplantation 
Human CD4+CD25+ Cells in Combination with CD34+ Cells and Thymoglobulin to Prevent Anti-hematopoietic Stem Cell T Cell Alloreactivity  Dolores Mahmud,
Adoptive Cellular Therapy using Cells Enriched for NKG2D+CD3+CD8+T Cells after Autologous Transplantation for Myeloma  Kenneth R. Meehan, Laleh Talebian,
FLT3 ligand administration after hematopoietic cell transplantation increases circulating dendritic cell precursors that can be activated by CpG oligodeoxynucleotides.
Allogeneic Stem Cell Transplantation in Myelofibrosis
Definition of the Variables Affecting Efficacy of Immunodepletion Ex Vivo of Peripheral Blood Progenitor Cell Grafts by Alemtuzumab (Campath in the Bag) 
Growth factors mobilize CXCR4 low/negative primitive hematopoietic stem/progenitor cells from the bone marrow of nonhuman primates  Nadim Mahmud, Hetal.
Characterizing Donor-Derived Cells in Nonhematopoietic Tissue
Partial T Cell-Depleted Allogeneic Stem Cell Transplantation following Reduced- Intensity Conditioning Creates a Platform for Immunotherapy with Donor.
Minor histocompatibility antigen-specific cytotoxic T lymphocytes generated with dendritic cells from DLA-identical littermates  George E. Georges, Marina.
Carbon Monoxide Diffusion Capacity: How Low Can You Go for Hematopoietic Cell Transplantation Eligibility?  Jason W. Chien, Keith M. Sullivan  Biology.
Dendritic Cells in Transplantation and Immune-Based Therapies
Expansion and Homing of Adoptively Transferred Human Natural Killer Cells in Immunodeficient Mice Varies with Product Preparation and In Vivo Cytokine.
Lisa A. Palmer, George E. Sale, John I
T Cell–Mediated Rejection of Human CD34+ Cells Is Prevented by Costimulatory Blockade in a Xenograft Model  Annie L. Oh, Dolores Mahmud, Benedetta Nicolini,
Claudio G. Brunstein, Bruce R. Blazar, Jeffrey S
Murine Bone Marrow Stromal Progenitor Cells Elicit an In Vivo Cellular and Humoral Alloimmune Response  Andrea T. Badillo, Kirstin J. Beggs, Elisabeth.
Effect of Ex Vivo Culture of CD34+ Bone Marrow Cells on Immune Reconstitution of XSCID Dogs Following Allogeneic Bone Marrow Transplantation  Douglas.
Mesenchymal Stromal Cells Fail to Prevent Acute Graft-versus-Host Disease and Graft Rejection after Dog Leukocyte Antigen-Haploidentical Bone Marrow Transplantation 
Volume 37, Issue 5, Pages (November 2012)
Atul Sathe, Sterling B. Ortega, Dorothy I. Mundy, Robert H
Plerixafor Plus Granulocyte Colony-Stimulating Factor versus Placebo Plus Granulocyte Colony-Stimulating Factor for Mobilization of CD34+ Hematopoietic.
Quantitation of Human Cells that Produce Neutrophils and Platelets in Vivo Obtained from Normal Donors Treated with Granulocyte Colony–Stimulating Factor.
Factors Associated with Peripheral Blood Stem Cell Yield in Volunteer Donors Mobilized with Granulocyte Colony-Stimulating Factors: The Impact of Donor.
Heterogeneous Clearance of Antithymocyte Globulin after CD34+-Selected Allogeneic Hematopoietic Progenitor Cell Transplantation  Irina Kakhniashvili,
B Cells and Transplantation: An Educational Resource
B7.2−/− Mature Dendritic Cells Generate T-Helper 2 and Regulatory T Donor Cells in Fetal Mice after In Utero Allogeneic Bone Marrow Transplantation  Swati.
A comparison of gene transfer and antigen-loaded dendritic cells for the generation of CD4+ and CD8+ cytomegalovirus-specific T cells in HLA-A2+ and HLA-A2−
Favorable Overall Survival with Fully Myeloablative Allogeneic Stem Cell Transplantation for Follicular Lymphoma  John Kuruvilla, Gregory Pond, Richard.
Protective Immunity Transferred by Infusion of Cytomegalovirus-Specific CD8+ T Cells within Donor Grafts: Its Associations with Cytomegalovirus Reactivation.
CpG-Induced Myeloid CD11b+Gr-1+ Cells Efficiently Suppress T Cell–Mediated Immunoreactivity and Graft-Versus-Host Disease in a Murine Model of Allogeneic.
CD25 expression distinguishes functionally distinct alloreactive CD4+ CD134+ (OX40+) T-cell subsets in acute graft-versus-host disease  Philip R Streeter,
Allogeneic Stem Cell Transplantation for Aplastic Anemia
Early Vaccination with Tumor Lysate-Pulsed Dendritic Cells after Allogeneic Bone Marrow Transplantation Has Antitumor Effects  Jeffrey S. Moyer, Gabriel.
Pauline Damien, David S. Allan 
What is quality in a transplant program?
Issues of Aging and Geriatric Medicine: Relevance to Cancer Treatment and Hematopoietic Reconstitution  William B. Ershler, Andrew S. Artz, Evan T. Keller 
Cord Blood Nucleated Cells Induce Delayed T Cell Alloreactivity
Biology of Blood and Marrow Transplantation
Allogeneic Hematopoietic Stem Cell Transplantation in FLT3-ITD–Positive Acute Myelogenous Leukemia: The Role for FLT3 Tyrosine Kinase Inhibitors Post-
Systemic Toxoplasmosis Post Allogeneic Stem Cell Transplantation (Allo-SCT): Lessons Learned from HIV?  Marie von Lilienfeld-Toal, MD, Maria Gilleece,
Blood and Marrow Transplant Handbook
Donation Activities and Product Integrity in Unrelated Donor Allogeneic Hematopoietic Transplantation: Experience of the National Marrow Donor Program 
Marco Mielcarek, Kristin A
Pharmacological Immunosuppression Reduces But Does Not Eliminate the Need for Total-Body Irradiation in Nonmyeloablative Conditioning Regimens for Hematopoietic.
Superior depletion of alloreactive T cells from peripheral blood stem cell and umbilical cord blood grafts by the combined use of trimetrexate and interleukin-2.
Mammen Chandy  Biology of Blood and Marrow Transplantation 
Allogeneic Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for Treatment of Marrow Failure Disorders  Lauri M. Burroughs, Akiko.
Reduced Intensity Conditioning for Allogeneic Hematopoietic Cell Transplantation: Current Perspectives  Brenda M. Sandmaier, Stephen Mackinnon, Richard.
Treatment versus Transplant for Challenging Hematologic Disorders
Hematopoietic cell transplantation from related and unrelated donors after minimal conditioning as a curative treatment modality for severe paroxysmal.
Early Recovery of CD4 T Cell Receptor Diversity after “Lymphoablative” Conditioning and Autologous CD34 Cell Transplantation  Jan Storek, Zhao Zhao, Yiping.
Evaluation of a CD25-specific immunotoxin for prevention of graft-versus-host disease after unrelated marrow transplantation  Paul J. Martin, Ji Pei,
What Role Is There for Antithymocyte Globulin in Allogeneic Nonmyeloablative Canine Hematopoietic Cell Transplantation?  Razvan Diaconescu, Marie-Térèse.
Outcomes among Patients with Recurrent High-Risk Hematologic Malignancies after Allogeneic Hematopoietic Cell Transplantation  Marco Mielcarek, Barry.
Mary Eapen  Biology of Blood and Marrow Transplantation 
Futility of Relapsed Diffuse Large B Cell Lymphoma Transplantation?
Older Age But Not Donor Health Impairs Allogeneic Granulocyte Colony-Stimulating Factor (G-CSF) Peripheral Blood Stem Cell Mobilization  Elie Richa, Mona.
Optimal Donor Selection: Beyond HLA
Graft Monocytic Myeloid-Derived Suppressor Cell Content Predicts the Risk of Acute Graft-versus-Host Disease after Allogeneic Transplantation of Granulocyte.
Presentation transcript:

Identification and Characterization of Canine Dendritic Cells Generated In Vivo  Marco Mielcarek, Kristin A. Kucera, Richard Nash, Beverly Torok-Storb, Hilary J. McKenna  Biology of Blood and Marrow Transplantation  Volume 13, Issue 11, Pages 1286-1293 (November 2007) DOI: 10.1016/j.bbmt.2007.07.010 Copyright © 2007 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 1 Allostimulatory potential of unsorted peripheral blood leukocytes obtained from dogs before (pre-FL) and after (post-FL) completion of 10 days of Flt3-ligand (FL) treatment. Different numbers of stimulators cells (5-20 × 104) obtained from dogs pre-FL and post-FL (100 μg/kg/day given subcutaneously for 10 days) were incubated with constant numbers (1 × 105) of allogeneic, third-party responder cells as described in Materials and Methods. Shown is one representative experiment of 5 experiments. Compared to untreated control dogs, FL treatment increased the MLC allostimulatory potential of unsorted peripheral blood leukocytes by a median of 150% (range: 36%-900%). Biology of Blood and Marrow Transplantation 2007 13, 1286-1293DOI: (10.1016/j.bbmt.2007.07.010) Copyright © 2007 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 2 Fluorescence activated cell sorting of phenotypically distinct cell populations from peripheral blood of FL-treated dogs. FSC/SSC characteristics of peripheral blood leukocytes before (A) and after (B) 10 days of FL treatment (100 μg/kg/day). Phenotypically distinct cell populations were sorted from post-FL peripheral blood as described in Materials and Methods. The following gates were combined with Gate 1, which was established according to FSC/SSC characteristics: Gate 2 for B lymphocytes (C); Gates 3 and 4 for monocytes and granulocytes, respectively (D); and Gates 5 and 6 for CD4 and CD8 T cells, respectively (E). Purity of sorted cell populations was ≥97%. CD34+ progenitor cells were not used as stimulator cells in MLC (F). Biology of Blood and Marrow Transplantation 2007 13, 1286-1293DOI: (10.1016/j.bbmt.2007.07.010) Copyright © 2007 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 3 Phenotypic characterization of putative dendritic cells (DC). Putative canine DC were sorted from post-FL blood using a 3-step approach. First, cell debris was excluded by establishing a gate according to FSC/SSC characteristics (Gate 1) (A). Second, Gate 2 was chosen to exclude all cells that were CD14+ (monocytes) and DM5+ (granulocytes) (B). Third, HLA-DR+/CD11c+ cells (R5) were collected (C). Thus, putative DC were defined as live gated cells that were HLA-DR+/CD11c+/DM5−/CD14−. Biology of Blood and Marrow Transplantation 2007 13, 1286-1293DOI: (10.1016/j.bbmt.2007.07.010) Copyright © 2007 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 4 Functional characterization of sorted cell populations in mixed lymphocyte cultures. Phenotypically distinct cells populations were sorted from FL-treated dogs as described in Materials and Methods. Varying numbers (5-20 × 103) of irradiated stimulator cells were placed into mixed lymphocyte cultures using constant numbers (1 × 105) of allogeneic, third-party responder cells. Shown is 1 of 6 representative experiments. Biology of Blood and Marrow Transplantation 2007 13, 1286-1293DOI: (10.1016/j.bbmt.2007.07.010) Copyright © 2007 American Society for Blood and Marrow Transplantation Terms and Conditions

Figure 5 Transmission electron microscopy of sorted putative dendritic cells. CD11c+/HLA-DR+/DM5−/CD14− cells were sorted and examined by transmission electron microscopy as described in Materials and Methods. The purity of the sorted population was 97%. In contrast to macrophages, which frequently displayed large and dark phagocytic vacuoles (A; closed arrowhead), putative DC were characterized by long cytoplasmic processes (B,C), only small, if any, lysosomal organelles (B,C), and an abundant Golgi apparatus and endoplasmic reticulum (D). Multivesicular bodies (A and C; open arrowheads). Biology of Blood and Marrow Transplantation 2007 13, 1286-1293DOI: (10.1016/j.bbmt.2007.07.010) Copyright © 2007 American Society for Blood and Marrow Transplantation Terms and Conditions